首页|基于脂质组学探讨鳖甲煎丸治疗非酒精性脂肪性肝炎的作用机制

基于脂质组学探讨鳖甲煎丸治疗非酒精性脂肪性肝炎的作用机制

扫码查看
研究鳖甲煎丸对非酒精性脂肪性肝炎(non-alcoholic steatohepatitis,NASH)小鼠肝脂质代谢的影响,探讨鳖甲煎丸调控NASH小鼠脂质代谢和炎症反应的作用机制。通过高脂高胆固醇饲料喂养C57BL/6 小鼠建立NASH模型,给予鳖甲煎丸干预,通过血清和肝脏生化指标及肝脏组织病理学检测评价鳖甲煎丸对NASH小鼠的治疗效果,应用UPLC-Q-TOF-MS技术检测肝脏的脂质代谢物,结合偏最小二乘法判别分析、t检验和受试者工作特征曲线分析筛选差异脂质和主要生物标志物;结合生物标志物结果,利用Western blot和qPCR检测脂质代谢及炎性相关分子。结果表明,鳖甲煎丸能显著降低NASH小鼠血清中谷丙转氨酶(alanine aminotransferase,ALT)、谷草转氨酶(aspartate aminotransferase,AST)、碱性磷酸酶(alkaline phosphatase,ALP)水平和肝组织中甘油三酯(triglyceride,TG)、总胆固醇(total cholesterol,TC)含量,抑制肝脏脂滴堆积、肝细胞气球样变和纤维化病变;脂质代谢组学结果显示,鳖甲煎丸可调控磷脂酰胆碱(phosphatidyl choline,PC)、磷脂酰乙醇胺(phosphatidyl etha-nolamine,PE)、鞘磷脂(sphingomyelin,SM)、神经酰胺(ceramide,Cer)等NASH相关 11 种脂质标志物;Western blot和qPCR结果显示,鳖甲煎丸可调控固醇调节元件结合蛋白1(sterol regulatory element-binding protein 1,SREBP1)、过氧化物酶体增殖物激活受体γ(peroxisome proliferator-activated receptor gamma,PPARγ)和磷酸化腺苷酸活化蛋白激酶(phospho-AMP-activated pro-tein kinase,p-AMPK)等脂质代谢相关蛋白的表达,及脂肪酸转位酶36(fatty acid translocase 36,Cd36)、Pparγ、心磷脂合酶 1(car-diolipin synthase 1,Crls1)和磷脂酶Cβ2(phospholipase Cβ2,Plcβ2)mRNA水平;抑制磷酸化p38 丝裂原活化蛋白激酶(phospho-p38 mitogen-activated protein kinase,p-p38 MAPK)、磷酸化细胞外调节蛋白激酶 1/2(phospho-extracellular signal regulated kinase 1/2,p-ERK1/2)和促炎因子 Il-6、Il-1β、Tnf-α mRNA 表达。综上所述,鳖甲煎丸可调节 PC、PE、SM、Cer 等脂类代谢,调控p-AMPK、SREBP1、PPARγ和Cd36、Crls1、Plcβ2 等脂质调控因子表达,改善脂质代谢紊乱,同时还能抑制MAPK信号通路和促炎因子mRNA水平,缓解炎症反应,发挥治疗NASH的作用。
Mechanism of Biejiajian Pills against non-alcoholic steatohepatitis based on lipidomics
This study aims to explore the potential mechanism of Biejiajian Pills in the treatment of non-alcoholic steatohepatitis(NASH)based on lipidomics.A mouse model of NASH was induced by high-fat/high cholesterol diet,and the mice of the normal group were fed with a normal diet.The therapeutic efficacy of Biejiajian Pills against NASH was evaluated through biochemical indexes in both of serum and liver,as well as the hepatic histopathology.Lipid metabolites in the liver were detected by ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry(UPLC-Q-TOF-MS)-based lipidomics.Then the partial least-squares discriminant analysis,t-test and receiver operating characteristic curve analysis were performed to screen the differential lipid metabolites and the main biomarkers.The proteins and genes involved in the lipid metabolism and inflammatory response were detected by Western blot and qPCR.The results demonstrated that Biejiajian Pills notably lowered the levels of alanine aminotransferase(ALT),aspartate aminotransferase(AST),and alkaline phosphatase(ALP)in the serum and the levels of triglyceride(TG)and total cholesterol(TC)in the liver tissue.In addition,Biejiajian Pills alleviated the lipid accumulation,hepatocyte ballooning,and liver fibrosis.Lipidomics revealed that Biejiajian Pills regulated the content of 11 biomarkers including phosphatidyl choline(PC),phosphatidyl ethanolamine(PE),sphingomyelin(SM),and ceramide(Cer).The results of Western blot and qPCR demonstrated that Biejiajian Pills regulated the expression of sterol regulatory element-binding protein 1(SREBP1),peroxisome proliferator-activated receptor gamma(PPARγ)and phospho-AMP-activated protein kinase(p-AMPK),and the mRNA level of fatty acid translocase 36 gene(Cd36),Pparγ,cardiolipin synthase 1 gene(Crls1),and phospholipase Cβ2 gene(Plcβ2).Furthermore,Biejiajian Pills displayed inhibitory effects on phospho-p38 MAPK(p-p38 MAPK)and phospho-ERK1/2(p-ERK1/2)and the mRNA levels of interleukin-6 gene(Il-6),interleukin-1β gene(Il-1β)and tumor necrosis factor-α gene(Tnf-α).In conclusion,Biejiajian Pills could alleviate the lipid metabolism disorders and regulate the expression of SREBP1,PPARγ,and p-AMPK and the mRNA levels of pro-inflammatory cytokines.

Biejiajian Pillsnon-alcoholic steatohepatitis(NASH)lipidomicsAMPKMAPK

黄菊、王梦玲、周子玥、闫婷、熊慧、梅之南

展开 >

中南民族大学 药学院,湖北 武汉 430074

华中农业大学 植物科学技术学院,湖北 武汉 430070

鳖甲煎丸 非酒精性脂肪性肝炎(NASH) 脂质组学 AMPK MAPK

国家重点研发计划湖北省自然科学基金

2022YFC35022002023AFB755

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(10)
  • 28